I agree that I'm for the resolutions in the proxy. Reverse splits get a bad name because most are executed by failing companies, and thus they eventually fail. It's tautological - failing companies fail at an exceedingly high rate. However, we wouldn't all be heavily invested here if we thought CytoDyn was a failing company. Well, at least I can confirm that I wouldn't be invested here if I thought that.
Since we think this has legitimate, lucrative prospects, I feel we need to give management every available tool to generate the most momentum and value possible through a potential series of key catalysts. To me, that includes the ability to reverse split for the purpose of uplisting to the NASDAQ in the event that share price doesn't warrant the uplist organically. Some might say that they don't trust management with the ability to reverse split with large ratios, etc. I go back to the same sort of logic - if I didn't trust management to run the company well, I wouldn't be invested here.
We want to be on the big stage when we drop big news. Obviously, my opinion!